Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical response and side effects of metoclopramide: associations with clinical, demographic, and pharmacogenetic parameters.

Journal of clinical gastroenterology - 1 Jul 2012

Parkman Henry P, Mishra Anurag, Jacobs Michael, Pathikonda Murali, Sachdeva Priyanka, Gaughan John, Krynetskiy Evgeny

Abstract excerpt

OBJECTIVES: Metoclopramide is associated with variable efficacy and side effects when used in the treatment of gastroparesis. AIM: To determine associations of clinical and pharmacogenetic parameters with response and side effects to metoclopramide in patients with upper gastrointestinal symptoms...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Body Mass Index
Share to Diabetes Mellitus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dopamine Antagonists

Share to Dose-Response Relationship, Drug

Share to Pharmacogenetics

Share to Sex Factors

Share to Treatment Outcome

Source

Identifiers

PMID: 22688145
DOI: 10.1097/MCG.0b013e3182522624

Genes

KCNH2
HTR4
ABCB1
DRD2
DRD3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22688145-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical response and side effects of metoclopramide: associations with clinical, demographic, and pharmacogenetic parameters.PMID 22688145Read ↗

Domperidone treatment for gastroparesis: demographic and pharmacogenetic characterization of clinical efficacy and side-effects.Semantic proximity Read ↗

Pharmacogenetics and the Treatment of Functional Gastrointestinal DisordersSemantic proximity Read ↗

Effects of CYP2D6 genetic polymorphism on the pharmacokinetics of metoclopramide.Semantic proximity Read ↗

An exploratory study of the association of adrenergic and serotonergic genotype and gastrointestinal motor functions.Semantic proximity Read ↗

Association of the 1438G/A and 102T/C Polymorphism of the 5-HT2A Receptor Gene With Irritable Bowel Syndrome 5-HT2A Gene Polymorphism in Irritable Bowel SyndromeSemantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy.Semantic proximity Read ↗

Pharmacological Effects and Toxicogenetic Impacts of Omeprazole: Genomic Instability and CancerSemantic proximity Read ↗

Maintenance therapy with zuclopenthixol decanoate: associations between plasma concentrations, neurological side effects and CYP2D6 genotypeSemantic proximity Read ↗

CYP2D6 isoenzyme and ABCB1 gene polymorphisms associated with postoperative nausea and vomiting in women undergoing laparoscopic cholecystectomy: a randomized trial.Semantic proximity Read ↗

[Rationale and methods of the UNAMET study (dose- and CYP2D6-genotype-dependent adverse drug reactions of metoprolol)--a contribution to quality improvement in pharmacotherapy].Semantic proximity Read ↗

CYP2D6 genotype and associated 5-HT3 receptor antagonist outcomes: A systematic review and meta-analysis.Semantic proximity Read ↗

Pharmacogenetics of low dose clonidine in irritable bowel syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.